Ocular Therapeutix (OCUL) Treasury Shares (2014 - 2025)

Ocular Therapeutix's Treasury Shares history runs 5 years deep, the most recent figure standing at $4.4 million for Q4 2025.

• In Q4 2025, Treasury Shares rose 28.61% year-over-year to $4.4 million; the TTM figure through Dec 2025 stood at $4.4 million (up 28.61% YoY), while the FY2025 annual figure was $4.4 million, up 28.61% from the prior year.
• Treasury Shares was $4.4 million for Q4 2025 at Ocular Therapeutix, up from $3.4 million in the prior quarter.
• In the past five years, Treasury Shares ranged from a high of $4.4 million in Q4 2025 to a low of $1.1 million in Q4 2022.
• Historically, Treasury Shares has averaged $2.6 million across 4 years, with a median of $2.5 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Treasury Shares surged 108.29% in 2024, then gained 28.61% in 2025.
• A 4-year view of Treasury Shares shows it stood at $1.1 million in 2022, then soared by 48.93% to $1.6 million in 2023, then soared by 108.29% to $3.4 million in 2024, then advanced by 28.61% to $4.4 million in 2025.
• The last three Treasury Shares figures came in at $4.4 million (Q4 2025), $3.4 million (Q4 2024), and $1.6 million (Q4 2023), per Business Quant data.